TrialThorax2022

Six-month and 12-month patient outcomes based on inflammatory subphenotypes in sepsis-associated ARDS: secondary analysis of SAILS-ALTOS trial.

Mohamed D Hashem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.